Immediate Termination of Study by CRO or Pfizer Sample Clauses

Immediate Termination of Study by CRO or Pfizer. CRO or Pfizer may terminate the Study immediately upon written notice to Institution for causes that include failure to enroll Study Subjects at a rate sufficient to achieve Study performance goals; material unauthorize d deviations from the Protocol or reporting requirement (2) Okamžité ukončení Studie ze strany CRO nebo společnosti Pfizer. CRO nebo společnost Pfizer může Studii ukončit s okamžitou účinností na základě písemného oznámení podaného Instituci z důvodů, mezi které patří nezařazení dostatečného počtu účastníků pro dosažení cílů Studie; podstatné neoprávněné odchylky od Protokolu s; circumstanc es that in CRO’s or Pfizer’s opinion pose risks to the health or well-being of Study Subjects; regulatory authority actions relating to the Study or the Investigatio nal Drug; any non- compliance by the Institution with local laws, ICH GCP, or the terms of Section 20 (Anti- Corruption) of this Agreement; or non- compliance by the Principal Investigator with the comparable terms of the agreement between CRO and Principal Investigator. nebo od požadavků na podávání zpráv; okolnosti, které podle názoru CRO nebo společnosti Pfizer představují riziko pro zdraví nebo blaho subjektů Studie; kroky kontrolních úřadů v souvislosti se Studií nebo hodnoceným léčivem; jakékoli nedodržení místních zákonů, pokynů ICH GCP nebo podmínek článku 20 této Smlouvy (Protikorupční opatření) ze strany Instituce; nebo nedodržení srovnatelných podmínek smlouvy mezi CRO a Hlavním zkoušejícím ze strany Hlavního zkoušejícího.
AutoNDA by SimpleDocs
Immediate Termination of Study by CRO or Pfizer. CRO or Pfizer may terminate the Study immediately upon written notice to Principal Investigator and Institution for causes that include material unauthorized deviations from the Protocol or reporting requirements; circumstances that in CRO’s or Pfizer’s opinion pose risks to the health or well-being of Study Subjects; regulatory authority actions relating to the Study or the Investigational Drug; or any non-compliance by the Principal Investigator or Institution with local laws. ICH GCP, or the terms of Section 20 (Anti-Corruption) of this Agreement.
Immediate Termination of Study by CRO or Pfizer. CRO or Pfizer may terminate the Study immediately upon written notice to Institution for causes that include failure to enroll Study Subjects at a rate sufficient to achieve Study performance goals; material unauthorized deviations from the Protocol or reporting requirements; circumstances that in CRO’s or Pfizer’s opinion pose risks to the health or well-being of Study Subjects; regulatory authority actions relating to the Study or the Investigational Drug; termination of the associated agreement between CRO and Principal Investigator (see Section 1.3, Agreement between CRO and Principal Investigator): any non- compliance by the Institution with local laws, ICH GCP, or the terms of Section 20 (Anti- Corruption) of this Agreement; or non-compliance by the Principal Investigator with the comparable terms of the agreement between CRO and Principal Investigator.
Immediate Termination of Study by CRO or Pfizer. CRO or Pfizer may terminate the Study immediately upon written notice to Principal Investigator and Institution for causes that include failure to enroll Study Subjects at a rate sufficient to achieve Study performance goals; material unauthorized deviations from the Protocol or reporting requirements; (2) Okamžité ukončení Studie ze strany CRO nebo společnosti Pfizer. CRO nebo společnost Pfizer mohou Studii ukončit s okamžitou účinností na základě písemného oznámení podaného zdravotnickému zařízení a Hlavnímu zkoušejícímu z důvodů mezi které patří: nezařazení dostatečného počtu účastníků pro dosažení cílů Studie; podstatné neoprávněné circumstances that in CRO’s or Pfizer’s opinion pose risks to the health or well- being of Study Subjects; regulatory authority actions relating to the Study or the Investigational Drug; or any non- compliance by the Principal Investigator or Institution with local laws. ICH GCP, or the terms of Section 20 (Anti-Corruption) of this Agreement. odchylky od Protokolu nebo od požadavků na podávání zpráv o Studii; okolnosti, které podle názoru CRO nebo společnosti Pfizer představují riziko pro zdraví nebo blaho Subjektů studie; kroky kontrolních úřadů v souvislosti se Studií nebo Hodnoceným léčivem; nebo jakékoli nedodržení místních zákonů, pokynů ICH GCP nebo podmínek článku 20 této Smlouvy (Protikorupční opatření) ze strany Hlavního zkoušejícího nebo zdravotnického zařízení.
Immediate Termination of Study by CRO or Pfizer. CRO or Pfizer may terminate the Study immediately upon written notice to Principal Investigator and Institution for causes that include failure to enroll Study Subjects at a rate sufficient to achieve Study performance goals; material unauthorized deviations from the Protocol or reporting requirements; circumstances that in CRO’s or Pfizer’s opinion pose risks to the health or well-being of Study Subjects; regulatory authority actions relating to the Study or the Investigational Drug; or any non-compliance by the Principal Investigator or Institution with local laws. ICH GCP, or the terms of Section 20 (Anti- Corruption) of this Agreement.
Immediate Termination of Study by CRO or Pfizer. CRO or Pfizer may terminate the Study immediately upon written notice to Institution for causes that include failure to enroll Study Subjects at a rate sufficient to achieve Study performance goals; material unauthorized deviations from the Protocol or reporting requirements; circumstances that in CRO’s or Xxxxxx’x opinion pose risks to the health or well- being of Study Subjects; regulatory authority actions relating to the hlavným skúšajúcim podobných ustanovení zmluvy medzi CRO a hlavným skúšajúcim. (3) Okamžité ukončenie klinického skúšania inštitúciou. Inštitúcia môže okamžite ukončiť klinické skúšanie oznámením CRO, ak to požaduje

Related to Immediate Termination of Study by CRO or Pfizer

  • Immediate Termination The LHIN may terminate this Agreement immediately upon giving Notice to the HSP if: (1) the HSP is unable to provide or has discontinued the Services in whole or in part or the HSP ceases to carry on business; (2) the HSP makes an assignment, proposal, compromise, or arrangement for the benefit of creditors, or is petitioned into bankruptcy, or files for the appointment of a receiver; (3) the LHIN is directed, pursuant to the Act, to terminate this Agreement by the Minister or the Director; (4) the Home has been closed in accordance with the Act; or (5) as provided for in section 4.6, the LHIN does not receive the necessary funding from the MOHLTC.

  • Termination of Stopped Work If a stop work order is not canceled and the work covered by such order is terminated for default or convenience, the reasonable costs resulting from the stop work order shall be allowed by adjustment or otherwise.

  • Exercise After Termination of Employment (A) Except as the COMMITTEE may at any time provide, if the employment of PARTICIPANT with the COMPANY and the subsidiaries and affiliates of the COMPANY is terminated for any reason other than death or “total disability” (as defined below), the AWARD may be exercised (to the extent that PARTICIPANT was entitled to do so on the date of the termination of PARTICIPANT’s employment) at any time within three months after such termination of employment, subject to the provisions of Section 2(C) of this AGREEMENT, and shall then expire. To the extent PARTICIPANT was not entitled to exercise the AWARD on the date of termination of PARTICIPANT’s employment, such portion of the AWARD shall expire on the date of such termination. (B) If PARTICIPANT becomes totally disabled, the AWARD shall become immediately vested and exercisable in full, and the AWARD may be exercised at any time during the first twelve (12) months that PARTICIPANT receives benefits under the Abercrombie & Fitch Co. Long Term Disability Plan, or any successor plan or program, subject to the provisions of Section 2(C) of this AGREEMENT, and shall then expire. (C) If PARTICIPANT dies while employed by the COMPANY or one of the subsidiaries or affiliates of the COMPANY, the AWARD shall become immediately vested and exercisable in full by PARTICIPANT’s estate or by the person who acquires the right to exercise the AWARD upon PARTICIPANT’s death by bequest or inheritance. The AWARD may be exercised at any time within one year after the date of PARTICIPANT’s death, or such other period as the COMMITTEE may at any time provide, subject to the provisions of Section 2(C) of this AGREEMENT, and shall then expire. (D) For purposes of this AGREEMENT, “total disability” shall have the definition set forth in the Abercrombie & Fitch Co. Long Term Disability Plan, which definition is incorporated herein by reference.

  • Complete Disposal Upon Termination of Service Agreement Upon Termination of the Service Agreement Provider shall dispose or delete all Student Data obtained under the Service Agreement. Prior to disposition of the data, Provider shall notify LEA in writing of its option to transfer data to a separate account, pursuant to Article II, section 3, above. In no event shall Provider dispose of data pursuant to this provision unless and until Provider has received affirmative written confirmation from LEA that data will not be transferred to a separate account.

  • Payments Upon Termination of Employment (a) If during the Termination Period the employment of the Executive shall terminate, other than by reason of a Nonqualifying Termination, then the Company shall pay to the Executive (or the Executive's beneficiary or estate) within 30 days following the Date of Termination, as compensation for services rendered to the Company: (1) a cash amount equal to the sum of (i) the Executive's full annual base salary from the Company through the Date of Termination, to the extent not theretofore paid, (ii) the Executive's annual bonus in an amount at least equal to the highest annualized (for any fiscal year consisting of less than 12 full months or with respect to which the Executive has been employed by the Company for less than 12 full months) bonus paid or payable, including by reason of any deferral, to the Executive by the Company in respect of the three fiscal years of the Company (or such portion thereof during which the Executive performed services for the Company if the Executive shall have been employed by the Company for less than such three fiscal year period) immediately preceding the fiscal year in which the Change in Control occurs, multiplied by a fraction, the numerator of which is the number of days in the fiscal year in which the Change in Control occurs through the Date of Termination and the denominator of which is 365 or 366, as applicable, and (iii) any compensation previously deferred by the Executive (together with any interest and earnings thereon) and any accrued vacation pay, in each case to the extent not theretofore paid; plus (2) a lump-sum cash amount (subject to any applicable payroll or other taxes required to be withheld pursuant to Section 5) in an amount equal to (i) the Executive's highest annual base salary from the Company in effect during the 12-month period prior to the Date of Termination, plus (ii) the Executive's highest annualized (for any fiscal year consisting of less than 12 full months or with respect to which the Executive has been employed by the Company for less than 12 full months) bonus, paid or payable, including by reason of any deferral, to the Executive by the Company in respect of the five fiscal years of the Company (or such portion thereof during which the Executive performed services for the Company if the Executive shall have been employed by the Company for less than such five fiscal year period) immediately preceding the fiscal year in which the Change in Control occurs, provided, that any amount paid pursuant to this Section 3(a)(2) shall be paid in lieu of any other amount of severance relating to salary or bonus continuation to be received by the Executive upon termination of employment of the Executive under any severance agreement, plan, policy or arrangement of the Company. (b) For a period of eighteen months commencing on the Date of Termination, the Company shall continue to keep in full force and effect all policies of medical, accident, disability and life insurance with respect to the Executive and his dependents with the same level of coverage, upon the same terms and otherwise to the same extent as such policies shall have been in effect immediately prior to the Date of Termination and the Company shall pay all costs of the continuation of such insurance coverage. (c) For a period of twelve months commencing on the Date of Termination, the Executive shall receive outplacement assistance services from an outplacement agency selected by the Executive and the Company shall pay all costs of such services; provided that such costs shall not exceed $15,000 in the aggregate. (d) If during the Termination Period the employment of the Executive shall terminate by reason of a Nonqualifying Termination, then the Company shall pay to the Executive within 30 days following the Date of Termination, a cash amount equal to the sum of: (1) the Executive's full annual base salary from the Company through the Date of Termination, to the extent not theretofore paid, and (2) any compensation previously deferred by the Executive (together with any interest and earnings thereon) and any accrued vacation pay, in each case to the extent not theretofore paid.

  • Delivery of Materials upon Termination of Employment As requested by the Company, from time to time and upon the termination of the Executive's employment with (or services for) the Company for any reason, the Executive will promptly deliver to the Company all property of the Company in the Executive's possession or within his control, including, without limitation, all copies and embodiments, in whatever form or medium, of all Confidential Information or Intellectual Property (including written records, notes, photographs, manuals, notebooks, documentation, program listings, flow charts, magnetic media, disks, diskettes, tapes and all other materials containing any Confidential Information or Intellectual Property), irrespective of the location or form of such property and, if requested by the Company, will provide the Company with written confirmation that all such property has been delivered to the Company and/or deleted from computers, as applicable.

  • Forfeiture upon Termination of Status as a Service Provider Notwithstanding any contrary provision of this Award Agreement, the balance of the Restricted Stock Units that have not vested as of the time of Participant’s termination as a Service Provider for any or no reason and Participant’s right to acquire any Shares hereunder will immediately terminate.

  • CFR PART 200 Termination Termination for cause and for convenience by the grantee or subgrantee including the manner by which it will be effected and the basis for settlement. (All contracts in excess of $10,000) Pursuant to the above, when federal funds are expended by ESC Region 8 and TIPS Members, ESC Region 8 and TIPS Members reserves the right to terminate any agreement in excess of $10,000 resulting from this procurement process for cause after giving the vendor an appropriate opportunity and up to 30 days, to cure the causal breach of terms and conditions. ESC Region 8 and TIPS Members reserves the right to terminate any agreement in excess of $10,000 resulting from this procurement process for convenience with 30 days notice in writing to the awarded vendor. The vendor would be compensated for work performed and goods procured as of the termination date if for convenience of the ESC Region 8 and TIPS Members. Any award under this procurement process is not exclusive and the ESC Region 8 and TIPS reserves the right to purchase goods and services from other vendors when it is in the best interest of the ESC Region 8 and TIPS. Does vendor agree? Yes

  • Term; Termination of Agreement This Agreement shall continue in force for a period of one year from the date hereof, subject to an unlimited number of successive one-year renewals upon mutual consent of the parties. It is the duty of the Independent Directors to evaluate the performance of the Advisor annually before renewing the Agreement, and each such renewal shall be for a term of no more than one year.

  • Survival After Termination The agreement to arbitrate will survive the termination of this Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!